ClinicalTrials.Veeva

Menu

Hepatocellular Carcinoma in HIV-infected Patients (GEHEP-002)

H

Hospital Universitario de Valme

Status

Completed

Conditions

Hepatitis B Virus
Liver Cirrhosis
HIV
Hepatocellular Carcinoma
Chronic Hepatitis C

Study type

Observational

Funder types

Other

Identifiers

NCT02785835
GEHEP-002
RIS-VAC12 (Other Identifier)

Details and patient eligibility

About

Observational study. All HIV-infected patients who have been diagnosed of hepatocellular carcinoma (HCC), following the American Association for the Study of Liver Diseases (AASLD) criteria, in the participant centers are included. Epidemiological, clinical and laboratory data are collected. The clinical and epidemiological characteristics of HCC cases will be analyzed. The efficacy and outcomes after modalities of HCC therapy will be assessed. Mortality and its predictors will be also assessed. In those cases infected by hepatitis C virus (HCV), the impact of HCV therapy on outcomes will be analysed.

Enrollment

477 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • HIV infection
  • Diagnosis of hepatocellular carcinoma according to American Association for the Study of Liver Diseases (AASLD) criteria

Exclusion criteria

  • None

Trial contacts and locations

30

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems